Scholarlink

Introduction <p>Device-based therapies for treating atrial fibrillation (AF)&#xa0;episodes are limited. Using pulsed electric fields (PEF) to induce reversible electroporation of cardiac tissue may effectively terminate AF. Thus, we aimed to assess the feasibility of PEF delivery for converting atrial arrhythmias via reversible electroporation.</p> Methods and results <p>Four swine models were used in this acute study. Custom-made decapolar catheters for PEF delivery were deployed with the following configurations: (1) Endocardial right atrium (RA) and coronary sinus (CS), <i>n</i> = 2; and (2) Endocardial RA and epicardial left atrium (epiLA), <i>n</i> = 2. AF and atrial flutter (AFL) were induced with programmed stimulation. PEF delivery was performed using the BTX 830 generator. For each attempt, a single monophasic pulse at 10 or 20&#xa0;µs pulse width was administered, with voltage varied across attempts (range 750–3000&#xa0;V). Successful (type 1 and 2 breaks) and unsuccessful conversion attempts were recorded. Post-PEF signal changes and arrhythmias were identified.&#xa0;A total of 58 AF/AFL (28 and 30 respectively) episodes were induced. Of the 37 successful conversion attempts, 33 (89.1%) were type 1 breaks. Conversion success probabilities generally increased with higher voltages for both configurations. Greater than 70% conversion success was seen with ≥ 1500&#xa0;V for the RA/CS configuration and ≥ 2000&#xa0;V for the RA/epiLA configuration. Arrhythmias including intra-atrial delay and high-grade atrioventricular block were seen, usually following successive PEF deliveries. Significant muscle stimulation was provoked with the current experimental setup.</p> Conclusion <p>Termination of atrial arrhythmias with PEF delivery is feasible, although further work is required to optimize its efficacy and safety.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Atrial fibrillation and flutter conversion with pulsed electric field delivery: preclinical proof of concept

  • 期刊论文

  • 发表日期：

    2025年8月14日

查看全文
  • Nicholas Y. Tan,
  • Freddy Del-Carpio Munoz,
  • Jason A. Tri,
  • Taro Koya,
  • Naoto Otsuka,
  • Christopher V. DeSimone,
  • Suraj Yalamuri,
  • Elad Maor,
  • Quim Castellvi,
  • Antoni Ivorra,
  • Damijan Miklavčič,
  • Samuel J. Asirvatham

摘要

Introduction

Device-based therapies for treating atrial fibrillation (AF) episodes are limited. Using pulsed electric fields (PEF) to induce reversible electroporation of cardiac tissue may effectively terminate AF. Thus, we aimed to assess the feasibility of PEF delivery for converting atrial arrhythmias via reversible electroporation.

Methods and results

Four swine models were used in this acute study. Custom-made decapolar catheters for PEF delivery were deployed with the following configurations: (1) Endocardial right atrium (RA) and coronary sinus (CS), n = 2; and (2) Endocardial RA and epicardial left atrium (epiLA), n = 2. AF and atrial flutter (AFL) were induced with programmed stimulation. PEF delivery was performed using the BTX 830 generator. For each attempt, a single monophasic pulse at 10 or 20 µs pulse width was administered, with voltage varied across attempts (range 750–3000 V). Successful (type 1 and 2 breaks) and unsuccessful conversion attempts were recorded. Post-PEF signal changes and arrhythmias were identified. A total of 58 AF/AFL (28 and 30 respectively) episodes were induced. Of the 37 successful conversion attempts, 33 (89.1%) were type 1 breaks. Conversion success probabilities generally increased with higher voltages for both configurations. Greater than 70% conversion success was seen with ≥ 1500 V for the RA/CS configuration and ≥ 2000 V for the RA/epiLA configuration. Arrhythmias including intra-atrial delay and high-grade atrioventricular block were seen, usually following successive PEF deliveries. Significant muscle stimulation was provoked with the current experimental setup.

Conclusion

Termination of atrial arrhythmias with PEF delivery is feasible, although further work is required to optimize its efficacy and safety.

Graphical Abstract